[1-(indazol-7-yl)-3-methyl-1H-pyrazole-4-carbonyl]guanidine | 241802-37-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 英文名称: [1-(indazol-7-yl)-3-methyl-1H-pyrazole-4-carbonyl]guanidine
• 英文别名: N-carbamimidoyl-1-(1H-indazol-7-yl)-3-methylpyrazole-4-carboxamide
• CAS: 241802-37-9
• 化学式: C₁₃H₁₃N₇O
• 分子量: 283.293
• InChiKey: AVBATQOBXIRWGX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  128
• 氢给体数：
  3
• 氢受体数：
  3

文献信息

• [EN] COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISEASES<br/>[FR] COMPOSES POUR TRAITEMENT DES MALADIES CARDIO-VASCULAIRES
  申请人：PFIZER PROD INC

  公开号：WO2005079803A1

  公开（公告）日：2005-09-01

  Pharmaceutical compositions containing sodium-hydrogen exchanger type 1 (NHE-1) inhibitors in combination with Ca 2+ overload inhibitors, and the use of such combination inhibitors to treat, for example, cardiovascular disease, such as ischemia, particularly, perioperative myocardial ischemic injury in mammals, including humans, are disclosed.

  含有钠-氢交换型1（NHE-1）抑制剂与Ca2+超载抑制剂的药物组合，以及利用这种组合抑制剂治疗心血管疾病（如缺血），特别是哺乳动物（包括人类）中的围手术期心肌缺血性损伤的用途被披露。
• Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
  申请人：——

  公开号：US20020143026A1

  公开（公告）日：2002-10-03

  The present invention provides compounds of formula I 1 and pharmaceutically acceptable salts thereof. The formula I compounds induce mitotic arrest thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inducing mitotic arrest.

  本发明提供了I式化合物及其药用可接受的盐。公式I化合物诱导有丝分裂停滞，因此使它们可用作抗癌剂。公式I化合物还可用于治疗其他可以通过诱导有丝分裂停滞来治疗的疾病。
• [EN] CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES<br/>[FR] COMPOSES DE DIHYDROPYRIMIDINE CYANO-SUBSTITUES ET LEUR UTILISATION POUR TRAITER DES MALADIES
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2002079169A1

  公开（公告）日：2002-10-10

  The present invention provides compounds of formula (I), formula (I) and pharmaceutically acceptable salts thereof. The formula I compounds induce mitotic arrest thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inducing mitotic arrest.

  本发明提供了式(I)的化合物，式(I)和其药学上可接受的盐。式(I)化合物能够诱导有丝分裂停滞，因此它们可用作抗癌剂。式(I)化合物还可用于治疗其他可以通过诱导有丝分裂停滞来治疗的疾病。
• [EN] N-[(SUBSTITUTED FIVE-MEMBERED DI- OR TRIAZA DIUNSATURATED RING)CARBONYL] GUANIDINE DERIVATIVES FOR THE TREATMENT OF ISCHEMIA<br/>[FR] DERIVES DE LA N-[(A CYCLE DI OU TRIAZA DIINSATURE SUBSTITUE) CARBONYLE] GUANIDINE UTILISES POUR LE TRAITEMENT DE L'ISCHEMIE
  申请人：PFIZER PRODUCTS INC.

  公开号：WO1999043663A1

  公开（公告）日：1999-09-02

  (EN) NHE-1 inhibitors, methods of using such NHE-1 inhibitors and pharmaceutical compositions containing such NHE-1 inhibitors. The NHE-1 inhibitors are useful for the reduction of tissue damage resulting from tissue ischemia.(FR) L'invention porte sur des inhibiteurs du NHE-1, sur leurs procédés d'utilisation, et sur des préparations pharmaceutiques les contenant. Lesdits inhibiteurs servent à réduire les dommages tissulaires résultant de l'ischémie des tissus.

  NHE-1抑制剂，使用这种NHE-1抑制剂的方法以及含有这种NHE-1抑制剂的药物组合物。这些NHE-1抑制剂有助于减少组织缺血引起的组织损伤。
• Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
  申请人：——

  公开号：US20030008888A1

  公开（公告）日：2003-01-09

  The present invention provides compounds of formula I 1 and pharmaceutically acceptable salts thereof. The formula I compounds induce mitotic arrest thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inducing mitotic arrest.

  本发明提供了I1式化合物及其药学上可接受的盐。I式化合物诱导有丝分裂停滞，因此它们可用作抗癌剂。I式化合物还可用于治疗其他可以通过诱导有丝分裂停滞来治疗的疾病。